Kaszubski, J.; Gagat, M.; Grzanka, A.; Wawrzyniak, A.; Niklińska, W.; Łapot, M.; Żuryń, A.
Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy. Molecules 2024, 29, 5239.
https://doi.org/10.3390/molecules29225239
AMA Style
Kaszubski J, Gagat M, Grzanka A, Wawrzyniak A, Niklińska W, Łapot M, Żuryń A.
Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy. Molecules. 2024; 29(22):5239.
https://doi.org/10.3390/molecules29225239
Chicago/Turabian Style
Kaszubski, Jonatan, Maciej Gagat, Alina Grzanka, Agata Wawrzyniak, Wiesława Niklińska, Magdalena Łapot, and Agnieszka Żuryń.
2024. "Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy" Molecules 29, no. 22: 5239.
https://doi.org/10.3390/molecules29225239
APA Style
Kaszubski, J., Gagat, M., Grzanka, A., Wawrzyniak, A., Niklińska, W., Łapot, M., & Żuryń, A.
(2024). Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy. Molecules, 29(22), 5239.
https://doi.org/10.3390/molecules29225239